doi:10.3969/j.issn.1673-8640.2020.11.007

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 11

[1]	LYON A W,MANSOOR A,TROTTER M J.Urinary gems:acyclovir crystalluria[J]. Arch Pathol Lab Med,2002,126(6):753-754.
[2]	黄河. 临床阿昔洛韦导致急性肾功能损害2例的分析[J]. 医学信息(下旬刊),2010,23(5):135.
[3]	TUCKER W E Jr,MACKLIN A W,SZOT R J,et al. Preclinical toxicology studies with acyclovir:acute and subchronic tests[J]. Fundam Appl Toxicol. 1983,3(6):573-578.
[4]	PETERSLUND N A,LARSEN M L,MYGIND H.Acyclovir crystalluria[J]. Scand J Infect Dis,1988,20(2):225-228.
[5]	MASON W J,NICKOLS H H.Images in clinical medicine,crystalluria from acyclovir use[J]. N Engl J Med,2008,358(13):e14.
[6]	OBADA E N,LEVEL G,MATHIEU P,et al.Acute renal failure following a treatment with acyclovir[J]. Nephrol Ther,2010,6(2):125-127.
[7]	BOON M,VAN DE VEN J,VAN MELSEN G C. A woman with needle-shaped crystals in the urine[J]. Ned Tijdschr Geneeskd,2014,158(6):A7206.
[8]	MENG J B,ZHENG X,ZHANG G,et al.Oral acyclovir induced acute renal failure[J]. World J Emerg Med,2011,2(4):310-313.
[9]	魏炯,胡爱琼. 阿昔洛韦致急性肾功能衰竭25例临床分析[J]. 四川医学,2013,34(5):676-678.
[10]	刘昌华,高波,陈蕊,等. 阿昔洛韦致急性肾损伤6例病理特点与临床分析[J]. 交通医学,2014,28(3):210-213.
[11]	房启麟,孙彬,李晓龙. 药物制剂的研究开发现状及展望[J]. 黑龙江医药,2011,24(5):803-804.

项目	BUN/（mmol/L）	SCr/（μmol/L）	UA/（mmol/L）	WBC计数/（×10⁹/L）	中性粒细胞百分比/%	尿蛋白	尿WBC	尿隐血	尿比重	尿pH值	尿沉渣镜检
2019年1月14日	10.76	124	445.7	10.14	81.6
2019年1月16日	13.48	66	274.7	6.90	78.2
2019年1月22日	9.50	160	244.0			3+	1+	3+	1.020	5.5	大量结晶,红细胞大量/高倍镜视野
2019年1月23日	11.85	244	308.0			±	1+	3+	1.005	6.0	未见结晶,红细胞3~5个/高倍镜视野
2019年1月24日	12.60	341	400.0			-	1+	3+	1.005	6.0	未见结晶,红细胞2~4个/高倍镜视野

项目	BUN/（mmol/L）	SCr/（μmol/L）	UA/（mmol/L）	WBC计数/（×10⁹/L）	中性粒细胞百分比/%	尿蛋白	尿WBC	尿隐血	尿比重	尿pH值	尿沉渣镜检
2019年1月14日	10.76	124	445.7	10.14	81.6
2019年1月16日	13.48	66	274.7	6.90	78.2
2019年1月22日	9.50	160	244.0			3+	1+	3+	1.020	5.5	大量结晶,红细胞大量/高倍镜视野
2019年1月23日	11.85	244	308.0			±	1+	3+	1.005	6.0	未见结晶,红细胞3~5个/高倍镜视野
2019年1月24日	12.60	341	400.0			-	1+	3+	1.005	6.0	未见结晶,红细胞2~4个/高倍镜视野

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 11

Related Articles 15

Recommended Articles

Metrics